Partnership &
Collaborations
At Grünenthal, we work closely with a number of partners to ensure that we are able to deliver the innovative pain solutions that our patients need. Working together, we want to share and build on our own expertise to remain at the forefront and keep pushing forward the worldwide fight against pain.
We use our resources and expertise to get access to funds for collaborative cutting-edge pain research and translate this to improved, real-world outcomes.
We work with the world’s biggest public-private partnership organisation in the life sciences as co-leaders of the latest pain initiative.
The genetics of pain; helping to identify new treatments for patients.
Latest Updates
PainSpectrum – What, how, who?
Are you interested to learn more about how the PainSpectrum was developed and the reasoning behind it? Read our introductory article to the PainSpectrum here.
Discover morePsychosocial Factors in Profiling IBS Patients
Read our article on how relevant the neuro-visceral axis is for the expression of symptoms from which visceral pain conditions, like IBS, can originate.
Discover moreOmics Approach to Identify Pain Pathways
Read our article about the steps we have taken to generate an integrated disease pathway map for pain which contains the major pathophysiological components.
Discover moreMechanisms of Placebo & Nocebo Responses in Clinical Trials
View Prof. Ulrike Bingel's (University Hospital Essen, Germany) third and final PainSolve webinar in her Placebo Effect series.
Discover more